REPLIGEN CORP Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REPLIGEN CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REPLIGEN CORP for March 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 31 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Gift | G | 0.00 | 350 | 0 | 7,494 | 7.8 K to 7.5 K (-4.46 %) |
Mar 31 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Gift | G | 0.00 | 750 | 0 | 7,844 | 8.6 K to 7.8 K (-8.73 %) |
Mar 22 2017 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Option Exercise | M | 4.29 | 20,000 | 85,800 | 0 | |
Mar 22 2017 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 34.12 | 2,521 | 86,017 | 93,243 | 95.8 K to 93.2 K (-2.63 %) |
Mar 22 2017 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Buy | M | 4.29 | 20,000 | 85,800 | 95,764 | 75.8 K to 95.8 K (+26.40 %) |
Mar 22 2017 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 6.23 | 10,000 | 62,300 | 0 | |
Mar 22 2017 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | M | 15.91 | 4,968 | 79,041 | 0 | |
Mar 22 2017 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 6.23 | 10,000 | 62,300 | 33,908 | 23.9 K to 33.9 K (+41.83 %) |
Mar 22 2017 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Sell | S | 34.63 | 7,248 | 251,010 | 23,908 | 31.2 K to 23.9 K (-23.26 %) |
Mar 22 2017 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Sell | S | 34.61 | 4,968 | 171,944 | 31,156 | 36.1 K to 31.2 K (-13.75 %) |
Mar 22 2017 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Buy | M | 15.91 | 4,968 | 79,041 | 36,124 | 31.2 K to 36.1 K (+15.95 %) |
Mar 22 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 3.22 | 4,000 | 12,880 | 1,000 | |
Mar 22 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 34.83 | 4,000 | 139,321 | 8,594 | 12.6 K to 8.6 K (-31.76 %) |
Mar 22 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 3.22 | 4,000 | 12,880 | 12,594 | 8.6 K to 12.6 K (+46.54 %) |
Mar 21 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | M | 24.50 | 4,000 | 98,000 | 6,000 | |
Mar 21 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Buy | M | 24.50 | 4,000 | 98,000 | 27,789 | 23.8 K to 27.8 K (+16.81 %) |
Mar 21 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 34.91 | 1,909 | 66,646 | 23,789 | 25.7 K to 23.8 K (-7.43 %) |
Mar 01 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | A | 32.32 | 19,750 | 638,320 | 19,750 | |
Mar 01 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Payment of Exercise | F | 32.07 | 1,630 | 52,273 | 25,698 | 27.3 K to 25.7 K (-5.96 %) |
Mar 01 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Grant | A | 0.00 | 9,875 | 0 | 27,328 | 17.5 K to 27.3 K (+56.58 %) |
Mar 01 2017 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Option Exercise | A | 32.32 | 64,975 | 2,099,992 | 64,975 | |
Mar 01 2017 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Payment of Exercise | F | 32.07 | 5,972 | 191,524 | 94,858 | 100.8 K to 94.9 K (-5.92 %) |
Mar 01 2017 | RGEN | REPLIGEN CORP | Hunt Anthony | Chief Executive Off ... | Grant | A | 0.00 | 32,488 | 0 | 100,830 | 68.3 K to 100.8 K (+47.54 %) |
Mar 01 2017 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Option Exercise | A | 32.32 | 9,012 | 291,268 | 9,012 | |
Mar 01 2017 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Payment of Exercise | F | 32.08 | 1,976 | 63,387 | 31,156 | 33.1 K to 31.2 K (-5.96 %) |
Mar 01 2017 | RGEN | REPLIGEN CORP | Benjamin Howard | VP Business Develop ... | Grant | A | 0.00 | 4,506 | 0 | 33,132 | 28.6 K to 33.1 K (+15.74 %) |